Overview Ketorolac in Breast Cancer Surgery Status: Completed Trial end date: 2018-09-01 Target enrollment: Participant gender: Summary Do the use of Ketorolac in one intravenous injection at the moment of the operative incision reduce the number of recurrence in patient with advanced breast cancer without inflammation signs. Phase: Phase 3 Details Lead Sponsor: Université Catholique de LouvainCollaborator: Anticancer Fund, BelgiumTreatments: KetorolacKetorolac Tromethamine